Press kit

Evocutis plc is a leading dermatology company uniquely able to combine contract research for laboratory testing, advanced living skin models and clinical testing to offer a complete service for the development of skin care products and their ingredients.

Our aim is to advance the discovery of products through scientific development and validation within the cosmetic, personal care, pharmaceutical and medical device sectors.

We have ambitious growth targets. Our strategy for achieving long-term growth is: Building on our established reputation in skin expertise by further development of our advanced, specialist laboratory and clinical evaluations of skin care products for the health and cosmetic markets and:Out-licensing internally-developed technologies and selectively building skin care brands.

Founded: 2003 as a spin-out of the world-renowned Skin Centre at the University of Leeds.

Country of Incorporation and Operation: United Kingdom.

Admission to AIM: 2006 as Syntopix Group plc (SYN). From 20 October 2011, as Evocutis plc (EVO).

Directors: Tom Bannatyne (Non-executive Chairman), Dr Stephen P Jones (CEO), Dr Richard A Bojar (CSO), Darren Bamforth (Finance Director), Dr Gwyn Humphreys (Senior Non-executive Director) and Mike Townend (Non-executive Director).

Click here to download the Evocutis Company Factsheet